02-08-2008, 10:01 AM
Patients with a certain gene variant drank less and experienced better overall clinical outcomes than patients without the variant while taking the medication naltrexone. About 87 percent of patients with the variant who received naltrexone experienced good outcomes, compared with about 49 percent of those who received a placebo.
Posted on Thu, 07 Feb 2008 00:00:00 EST at http://www.sciencedaily.com/releases/200...172332.htm
Posted on Thu, 07 Feb 2008 00:00:00 EST at http://www.sciencedaily.com/releases/200...172332.htm